Datamonitor -The Industry Analysis Experts are pleased to be able to bring
you this limited time FREE offer, giving you the chance to download the brief
"Peripheral Arterial Disease".
Inspired by the Sunday morning session, 11 November, of the American Heart Association
Scientific Sessions, 2001, Anaheim, this brief seeks to do the following:
Provide an overview of the spectrum of PAD from asymptomatic disease through to
intermittent claudication, claudication and critical limb ischemia with particular
reference to the consequences and risks associated with the PAD;
Estimate and forecast the prevalence of chronic PAD for the period to 2015;
Analyze the results of the PARTNERS program in the US and assess the commercial
implications of these findings;
Provide an overview of the non-pharmacological treatment options that available and
explain the increasing focus on pharmacotherapy for chronic PAD;
Examine the current drug therapies that are available for both symptomatic control and
secondary prevention in chronic PAD patients, assessing their potential in this population
and highlighting the unmet needs that exist;
Investigate the results of clinical trials on prostacyclin analogues in PAD, with a focus
on the somewhat surprising findings of the BIRO2 study on Beraprost;
Assess the future potential for gene therapy products in the treatment of PAD, providing
an analysis of the major products currently in human trials;
Examine other novel approaches, currently in development, including therapeutic proteins
and immune modulation therapy and assess the future direction of PAD therapy, identifying
the companies that are likely to benefit most from the changes that are taking place.
In order to download the FREE Cardiovascular Report simply complete the following form.
Your download will then be automated and as an added extra you will be subscribed to the
weekly Cardiovascular Digest and the monthly Monitor newsletters.
